Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt In addition, Outset has entered into a credit agreement and guaranty with a fund managed by ...

Outset Medical (NASDAQ:OM) has observed the following analyst ratings within the last quarter: In the last 3 months, 5 analysts have offered 12-month price targets for Outset Medical. The company has ...

Outset Medical, Inc. has appointed Renee Gaeta as its new Chief Financial Officer, effective immediately, succeeding Nabeel Ahmed who is leaving for other opportunities. Gaeta brings extensive ...

Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the United States. “With the FDA’s clearance of TabloCart with ...

Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest update ...

“Outset’s results in the first quarter reflect the strong progress we have made with our commercial transformation, the durable competitive differentiation of Tablo for acute and home hemodialysis, ...

SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...

Outset Medical, Inc. OM shares ended the last trading session 22.2% higher at $5.57. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Outset Medical, Inc.